Active, Not Recruiting
Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
NCT03114527
- Conditions
- Leiomyosarcoma, Liposarcoma, Neoplasms, +6 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States